{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:31:58Z","timestamp":1793255518958,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK007245"],"award-info":[{"award-number":["T32DK007245"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK007245"],"award-info":[{"award-number":["T32DK007245"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018242","name":"Michigan Nutrition Obesity Research Center","doi-asserted-by":"crossref","award":["F059720"],"award-info":[{"award-number":["F059720"]}],"id":[{"id":"10.13039\/100018242","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Michigan Caswell Diabetes Institute","award":["F052716"],"award-info":[{"award-number":["F052716"]}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K08HL147377"],"award-info":[{"award-number":["K08HL147377"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The objective of this report is to describe the successful use of diazoxide as a bridging therapy for a patient with opioid-induced hypoglycemia who was unable to immediately discontinue methadone treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 41-year-old male presented for an unrelated planned surgical procedure and was found to have symptomatic hyperinsulinemic hypoglycemia resulting from high-dose methadone prescribed for chronic pain in the setting of end stage renal disease requiring hemodialysis. Diazoxide was successfully used as a bridging therapy until he ultimately decided to discontinue methadone following a multidisciplinary discussion with endocrinology, internal medicine, and an addiction consultation team. During a 10-day admission for safety and observation of withdrawal, he was weaned from methadone and transitioned to buccal buprenorphine and eventually sub-lingual buprenorphine\/naloxone. After methadone was decreased and then discontinued, he was able to discontinue dextrose infusion and eventually diazoxide. Several months after discharge, he reported fasting blood glucose levels between 110 and 130\u00a0mg\/dL (6.11\u20137.22 mmol\/L; reference range 75\u2013115\u00a0mg\/dL; 4.16\u20136.38 mmol\/L) without symptoms of hypoglycemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>While diazoxide has been used as bridging therapy for insulinoma patients awaiting surgery, this report highlights the utility of the non-diuretic benzothiadiazine in opioid-induced hyperinsulinemic hypoglycemia. Patients with hyperinsulinemic hypoglycemia on high doses of tramadol or methadone should be transitioned off the offending agent; however, diazoxide is an effective, alternative option when the transition is not feasible or needs to be delayed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40842-025-00220-0","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T23:01:40Z","timestamp":1745535700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diazoxide as a bridging therapy in methadone-induced hypoglycemia\u2013 a case report and review of the literature"],"prefix":"10.1186","volume":"11","author":[{"given":"Katherine I.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia Hemmrich","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafaq","family":"Khairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7679-2484","authenticated-orcid":false,"given":"Eric D.","family":"Buras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"issue":"3","key":"220_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1210\/jc.2008-1410","volume":"94","author":"PE Cryer","year":"2009","unstructured":"Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(3):709\u201328. https:\/\/doi.org\/10.1210\/jc.2008-1410","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"220_CR2","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s11154-023-09828-y","volume":"24","author":"E Maines","year":"2023","unstructured":"Maines E, Urru SAM, Leonardi L, et al. Drug-Induced hyperinsulinemic hypoglycemia: an update on pathophysiology and treatment. Rev Endocr Metab Disord. 2023;24(6):1031\u201344. https:\/\/doi.org\/10.1007\/s11154-023-09828-y","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"220_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1210\/jc.2008-1416","volume":"94","author":"MH Murad","year":"2009","unstructured":"Murad MH, Coto-Yglesias F, Wang AT, et al. Drug-Induced hypoglycemia: A systematic review. J Endocrinol Metab. 2009;94(3):741\u20135. https:\/\/doi.org\/10.1210\/jc.2008-1416","journal-title":"J Endocrinol Metab"},{"issue":"4","key":"220_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10571-013-9919-6","volume":"33","author":"AJ Faskowitz","year":"2013","unstructured":"Faskowitz AJ, Kramskiy VN, Pasternak GW. Methadone-Induced hypoglycemia. Cell Mol Neurobiol. 2013;33(4):537\u2013. https:\/\/doi.org\/10.1007\/s10571-013-9919-6. \u200942.","journal-title":"Cell Mol Neurobiol"},{"issue":"10","key":"220_CR5","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/aas.12562","volume":"59","author":"J Gjedsted","year":"2015","unstructured":"Gjedsted J, Dall R. Severe hypoglycemia during methadone escalation in an 8-year-old child. Acta Anesthesiol Scan. 2015;59(10):1394\u20136. https:\/\/doi.org\/10.1111\/aas.12562","journal-title":"Acta Anesthesiol Scan"},{"issue":"1","key":"220_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/15563650.2017.1338347","volume":"56","author":"MS Toce","year":"2018","unstructured":"Toce MS, Stefater MA, Breault DT, et al. A case report of Methadone-Associated hypoglycemia in an 11-month-old male. Clin Toxicol. 2018;56(1):74\u20136. https:\/\/doi.org\/10.1080\/15563650.2017.1338347","journal-title":"Clin Toxicol"},{"issue":"2","key":"220_CR7","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1097\/MJT.0000000000000692","volume":"25","author":"CJ Plescia","year":"2018","unstructured":"Plescia CJ, Manu P. Hypoglycemia and sudden death during treatment with methadone for opiate detoxification. Am J Ther. 2018;25(2):e267\u20139. https:\/\/doi.org\/10.1097\/MJT.0000000000000692","journal-title":"Am J Ther"},{"key":"220_CR8","doi-asserted-by":"publisher","unstructured":"Masharani U, Alba D. Methadone-Associated hypoglycemia in chronic renal failure masquerading as an Insulinoma. Pain Med. 20185;19(9):1876\u20138. https:\/\/doi.org\/10.1093\/pm\/pnx280","DOI":"10.1093\/pm\/pnx280"},{"issue":"7","key":"220_CR9","doi-asserted-by":"publisher","first-page":"e245890","DOI":"10.1136\/bcr-2021-245890","volume":"15","author":"S Kanbour","year":"2022","unstructured":"Kanbour S, Balaju A, Chae K, et al. Insulinoma Mimic: methadone induced hypoglycemia. BMJ Case Rep. 2022;15(7):e245890. https:\/\/doi.org\/10.1136\/bcr-2021-245890","journal-title":"BMJ Case Rep"},{"key":"220_CR10","doi-asserted-by":"publisher","unstructured":"Malboosbaf R, Hatami N, Maghsoomi Z, Methadone-Induced Hypoglycemia. A case report. J Diabetes Invetig. 2023;14(1):145\u20136. https:\/\/doi.org\/10.1111\/jdi.13919","DOI":"10.1111\/jdi.13919"},{"issue":"6","key":"220_CR11","doi-asserted-by":"publisher","first-page":"e62903","DOI":"10.7759\/cureus.62903","volume":"16","author":"N Guevara","year":"2024","unstructured":"Guevara N, Chapiolkina V, Pesantez J, et al. A case report of challenging diagnosis of persistent hypoglycemia secondary to methadone Dose-Dependence in a patient with End-Stage-Renal disease (ESRD) and liver cirrhosis (LS). Cureus. 2024;16(6):e62903. https:\/\/doi.org\/10.7759\/cureus.62903","journal-title":"Cureus"},{"issue":"2","key":"220_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/00185787231207750","volume":"59","author":"DA Wells","year":"2024","unstructured":"Wells DA, Parnacott T, Volberding K, et al. Methadone-Induced hypoglycemia in a hospitalized patient. Hosp Pharm. 2024;59(2):149\u201351. https:\/\/doi.org\/10.1177\/00185787231207750","journal-title":"Hosp Pharm"},{"issue":"3","key":"220_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/15563650.2016.1277236","volume":"55","author":"ATY Li","year":"2017","unstructured":"Li ATY, Chu FKC. A case of massive methadone overdose presented with refractory hypoglycemia. Clin Toxicol (Phila). 2017;55(3):233. https:\/\/doi.org\/10.1080\/15563650.2016.1277236","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"220_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5055\/jom.2013.0144","volume":"9","author":"N Moryl","year":"2013","unstructured":"Moryl N, Pope J, Obbens E. Hypoglycemia during rapid methadone dose escalation. J Opioid Manag. 2013;9(1):29\u201334. https:\/\/doi.org\/10.5055\/jom.2013.0144","journal-title":"J Opioid Manag"},{"issue":"3","key":"220_CR15","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/0006-2952(93)90083-9","volume":"253","author":"DA Brase","year":"1990","unstructured":"Brase DA, Singha AK, Estrada E, et al. Hypoglycemia induced by intrathecal opioids in mice: sterospecificity, drug specificity, and effect of fasting. J Pharmacol Esp Ther. 1990;253(3):899\u2013904. https:\/\/doi.org\/10.1016\/0006-2952(93)90083-9","journal-title":"J Pharmacol Esp Ther"},{"issue":"1","key":"220_CR16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/14740338.2019.1646246","volume":"18","author":"B Chretien","year":"2019","unstructured":"Chretien B, Dolladille C, Hamel-Senecal L, et al. Comparative study of hypoglycemia induced by opioids. Is it a class effect?? Expert Opin Drug Saf. 2019;18(1):987\u201392. https:\/\/doi.org\/10.1080\/14740338.2019.1646246","journal-title":"Expert Opin Drug Saf"},{"key":"220_CR17","doi-asserted-by":"publisher","unstructured":"Makunts R, U A, Atayee RS et al. Retrospective Analysis Reveals Significant Association of Hypoglycemia with Tramadol and Methadone in Contrast to Other Opioids. Sci Rep. 2019 28;9(1):12490. https:\/\/doi.org\/10.1038\/s41598-019-48955-y","DOI":"10.1038\/s41598-019-48955-y"}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-025-00220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-025-00220-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-025-00220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T23:01:42Z","timestamp":1745535702000},"score":1,"resource":{"primary":{"URL":"https:\/\/clindiabetesendo.biomedcentral.com\/articles\/10.1186\/s40842-025-00220-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["220"],"URL":"https:\/\/doi.org\/10.1186\/s40842-025-00220-0","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Signed informed consent obtained directly from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}